(Q37559651)

21 August 2017

1 reference

title

Innate immune control of nucleic acid-based vaccine immunogenicity (English)

1 reference

21 August 2017

6

1 reference

21 August 2017

Shohei Koyama

1

0 references

Cevayir Coban

object named as

Cevayir Coban

series ordinal

2

0 references

Toshihiro Horii

object named as

Toshihiro Horii

series ordinal

4

0 references

Shizuo Akira

series ordinal

5

object named as

Shizuo Akira

1 reference

21 August 2017

Taiki Aoshi

3

1 reference

21 August 2017

publication date

1 August 2009

1 reference

Expert Review of Vaccines

21 August 2017

published in

1 reference

21 August 2017

volume

8

1 reference

21 August 2017

issue

8

1 reference

21 August 2017

page(s)

1099-1107

1 reference

Overview of vaccine adjuvants: present and future

21 August 2017

cites work

1 reference

Bridging the knowledge gaps in vaccine design

21 January 2018

1 reference

Translating innate immunity into immunological memory: implications for vaccine development

21 January 2018

1 reference

Targeting the innate immune response with improved vaccine adjuvants

21 January 2018

1 reference

Toll or toll-free adjuvant path toward the optimal vaccine development

21 January 2018

1 reference

Host innate immune receptors and beyond: making sense of microbial infections

21 January 2018

1 reference

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

21 January 2018

1 reference

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

21 January 2018

1 reference

Recognition of viral single-stranded RNA by Toll-like receptors

21 January 2018

1 reference

A Toll-like receptor recognizes bacterial DNA

21 January 2018

1 reference

The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation

21 January 2018

1 reference

Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms

21 January 2018

1 reference

Innate immune response to viral infection

21 January 2018

1 reference

RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates

21 January 2018

1 reference

Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5

21 January 2018

1 reference

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

21 January 2018

1 reference

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

21 January 2018

1 reference

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

21 January 2018

1 reference

VISA is an adapter protein required for virus-triggered IFN-beta signaling

21 January 2018

1 reference

STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling

21 January 2018

1 reference

The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation

21 January 2018

1 reference

ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization

21 January 2018

1 reference

Intracellular pattern recognition receptors in the host response

21 January 2018

1 reference

ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells

21 January 2018

1 reference

The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis

21 January 2018

1 reference

Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3

21 January 2018

1 reference

Critical role for Cryopyrin/Nalp3 in activation of caspase-1 in response to viral infection and double-stranded RNA

21 January 2018

1 reference

Inhibition of virus multiplication by foreign nucleic acid

21 January 2018

1 reference

Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides

21 January 2018

1 reference

A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA.

21 January 2018

1 reference

Recognition of cytosolic DNA activates an IRF3-dependent innate immune response

21 January 2018

1 reference

The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response

21 January 2018

1 reference

HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA

21 January 2018

1 reference

AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC

21 January 2018

1 reference

AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA

21 January 2018

1 reference

An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome

21 January 2018

1 reference

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

21 January 2018

1 reference

Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination

21 January 2018

1 reference

Inflammasome recognition of influenza virus is essential for adaptive immune responses

21 January 2018

1 reference

The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1

21 January 2018

1 reference

The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA.

21 January 2018

1 reference

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

21 January 2018

1 reference

Therapeutic potential of Toll-like receptor 9 activation

21 January 2018

1 reference

DNA vaccines: immunology, application, and optimization*

21 January 2018

1 reference

Molecular and cellular mechanisms of DNA vaccines

21 January 2018

1 reference

Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice

21 January 2018

1 reference

Nanotechnology in vaccine delivery

21 January 2018

1 reference

Virus-sized vaccine delivery systems

21 January 2018

1 reference

ISCOM-based vaccines: the second decade.

21 January 2018

1 reference

Cooperation of Toll-like receptor signals in innate immune defence

21 January 2018

1 reference

Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells

21 January 2018

1 reference

MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists

21 January 2018

1 reference

Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease

21 January 2018

1 reference

Synergy of CpG oligodeoxynucleotide and double-stranded RNA (poly I:C) on nitric oxide induction in chicken peripheral blood monocytes

21 January 2018

1 reference

Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

21 January 2018

1 reference

Improving vaccine delivery using novel adjuvant systems

21 January 2018

1 reference

Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant

21 January 2018

1 reference

Intranasal vaccines for protection against respiratory and systemic bacterial infections.

21 January 2018

1 reference

Sublingual vaccination with influenza virus protects mice against lethal viral infection

21 January 2018

1 reference

Protective attenuated lentivirus immunization induces SIV-specific T cells in the genital tract of rhesus monkeys.

21 January 2018

1 reference

Intrarectal vaccination with recombinant vaccinia virus expressing carcinoembronic antigen induces mucosal and systemic immunity and prevents progression of colorectal cancer

21 January 2018

1 reference

Dendritic cell (DC) based therapy for cervical cancer: use of DC pulsed with tumour lysate and matured with a novel synthetic clinically non-toxic double stranded RNA analogue poly [I]:poly [C(12)U] (Ampligen R).

21 January 2018

1 reference

Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine.

21 January 2018

1 reference

Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.

21 January 2018

1 reference

Inhibitory effect of the polyinosinic-polycytidylic acid/cationic liposome on the progression of murine B16F10 melanoma

21 January 2018

1 reference

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates

21 January 2018

1 reference

TLR7 imidazoquinoline ligand 3M-019 is a potent adjuvant for pure protein prototype vaccines.

21 January 2018

1 reference

Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses

21 January 2018

1 reference

5'-Triphosphate RNA is the ligand for RIG-I

21 January 2018

1 reference

TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.09.57

1 reference

21 August 2017

1 reference